By promoting muscle recovery and peptide synthesis, you can get back to your training regimen faster and stronger
While semaglutide is considered safe and effective for most patients, some may experience side effects, particularly in the early stages of treatment
Stop using EGRIFTA WR if any cancer symptoms come back
Insert the needle, flip the vial upside down, and slowly pull the plunger to your target volume
Serving patients from Cardiff, Swansea, Newport, Monmouthshire, Bridgend and across South Wales
Where they overlap and where they don't Complementary Mechanism Targets Target Origin BPC-157 Gastric juice protein fragment (15 amino acids) TB-500 Thymosin Beta-4 fragment (LKKTETQ region) Target Primary action BPC-157 Local tissue repair signaling TB-500 Systemic cell migration and mobilization Target Angiogenesis BPC-157 VEGF upregulation, NO pathway TB-500 Endothelial migration, VEGF crosstalk Target Cell migration BPC-157 Indirect, via growth factors TB-500 Direct (G-actin sequestering) Target Best-evidence tissue BPC-157 Tendon, gut, gastric mucosa (preclinical) TB-500 Cardiac, corneal, skin (preclinical + early human T4) Target Reported in vivo half-life BPC-157 ~4 hours (animal estimates) TB-500 ~23 days (animal estimates) Half-life figures are pharmacokinetic estimates from animal studies
